Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NATIONAL STOCK EXCHANGE OF INDIA  >  GlaxoSmithKline Pharmaceuticals Limited    GLAXO   INE159A01016

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote National Stock Exchange O…
11/15/2017 11/16/2017 11/17/2017 11/20/2017 11/21/2017 Date
2540(c) 2610(c) 2492(c) 2480(c) 2495 Last
7 776 11 480 26 029 10 810 11 834 Volume
-2.02% +2.76% -4.52% -0.48% +0.60% Change
More quotes
Financials ( INR)
Sales 2018 32 306 M
EBIT 2018 4 820 M
Net income 2018 3 755 M
Finance 2018 6 371 M
Yield 2018 1,83%
Sales 2019 36 260 M
EBIT 2019 6 019 M
Net income 2019 4 592 M
Finance 2019 7 826 M
Yield 2019 1,96%
P/E ratio 2018 56,07
P/E ratio 2019 46,96
EV / Sales2018 6,34x
EV / Sales2019 5,61x
Capitalization 211 B
More Financials
Company
GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals.The company's product portfolio includes prescription medicines and vaccines.Its prescription medicines range across therapeutic areas such as anti-infective, dermatology,... 
Sector
Pharmaceuticals
Calendar
12/19Business Plan 2018
More about the company
Surperformance© ratings of GlaxoSmithKline Pharmaceut
Trading Rating : Investor Rating :
More Ratings
Latest news on GLAXOSMITHKLINE PHARMACEUT
11/03 GLAXOSMITHKLINE : Cancer Treatment Gets FDA Breakthrough Therapy Designation
10/27 GLAXOSMITHKLINE PHARMACEUTICALS LIMI : records a Revenue increase of 5%
10/26 GLAXOSMITHKLINE PHARMACEUTICALS : Pharma Q2 net profit up 32% at Rs 130 crore
10/26 GLAXOSMITHKLINE PLC (ADR) (NYSE : GSK) Would Consider Acquiring Pfizer Inc. (NYS..
10/26 GLAXOSMITHKLINE PHARMACEUTICALS : Glaxo sales rise
10/26 PFIZER : Glaxo plots foreign takeover bonanza
10/26 GLAXOSMITHKLINE PHARMACEUTICALS : PHARMA Q2 NET PROFIT UP 32% AT Rs130 CRORE
10/25 GLAXOSMITHKLINE PHARMACEUTICALS : Panel recommends new, better shingles shot ove..
10/25 CORRECTION : FDA-Shingles Vaccine story
10/25 GLAXOSMITHKLINE PHARMACEUTICALS : records a Revenue increase of 5%
More news
Sector news : Pharmaceuticals - NEC
06:36a Exclusive - Prescient messages about Indian companies circulate in WhatsApp g..
11/20 ASTRAZENECA : EU drugs agency move to Amsterdam minimizes likely staff losses
11/20 ASTRAZENECA : EU drugs agency move to Amsterdam minimises likely staff losses
11/20 FTSE recoups early losses as cyclicals recover
11/20DJSHIRE : Appoints Thomas Dittrich as Chief Financial Officer
More sector news : Pharmaceuticals - NEC
Chart GLAXOSMITHKLINE PHARMACEUT
Duration : Period :
GlaxoSmithKline Pharmaceut Technical Analysis Chart | GLAXO | INE159A01016 | 4-Traders
Technical analysis trends GLAXOSMITHKLINE PHARMACEUT
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Average target price 2 338  INR
Spread / Average Target -6,2%
EPS Revisions
Managers
NameTitle
Annaswamy Vaidheesh Managing Director & Executive Director
Deepak Shantilal Parekh Non-Executive Chairman
Andrew Aristidou Chief Financial Officer & Executive Director
Raju Krishnaswamy Executive Director & Technical Director
Vrishali Desai Vice President-Medical & Clinical Research
Sector and Competitors
1st jan.Capitalization (M$)
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED-4.40%3 247
JOHNSON & JOHNSON19.78%370 552
NOVARTIS11.20%220 012
ROCHE HOLDING LTD.-1.55%212 913
PFIZER8.90%210 711
MERCK AND COMPANY-6.23%147 550